Literature DB >> 7603218

Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations.

H J Naurath1, E Joosten, R Riezler, S P Stabler, R H Allen, J Lindenbaum.   

Abstract

In a prospective, multicentre, double-blind controlled study, the effect of an intramuscular vitamin supplement containing 1 mg vitamin B12, 1.1 mg folate, and 5 mg vitamin B6 on serum concentrations of methylmalonic acid (MMA), homocysteine (HCYS), 2-methylcitric acid (2-MCA), and cystathionine (CYSTA) was compared with that of placebo in 175 elderly subjects living at home and 110 in hospital. Vitamin supplement and placebo were administered eight times over a 3-week period. Vitamin supplement but not placebo significantly reduced all four metabolite concentrations at the end of the study in both study groups. The maximum effects of treatment were usually seen within 5-12 days. Initially elevated metabolite concentrations returned to normal in a higher proportion of the vitamin than of the placebo group: 92% vs 20% for HYCS; 82% vs 20% for MMA; 62% vs 25% for 2-MCA; and 42% vs 25% for CYSTA. The response rate to vitamin supplements supports the notion that metabolic evidence of vitamin deficiency is common in the elderly, even in the presence of normal serum vitamin levels. Metabolite assays permit identification of elderly subjects who may benefit from vitamin supplements.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7603218     DOI: 10.1016/s0140-6736(95)92113-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  30 in total

1.  Utility of measuring vitamin B12 and its active fraction, holotranscobalamin, in neurological vitamin B12 deficiency syndromes.

Authors:  Wiebke Schrempf; Marco Eulitz; Volker Neumeister; Gabriele Siegert; Rainer Koch; Heinz Reichmann; Alexander Storch
Journal:  J Neurol       Date:  2010-10-02       Impact factor: 4.849

2.  Methylenetetrahydrofolate reductase gene polymorphism, homocysteine and risk of macroangiopathy in Type 2 diabetes mellitus.

Authors:  J Sun; Y Xu; Y Zhu; H Lu
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

Review 3.  Potential outcome factors in subacute combined degeneration: review of observational studies.

Authors:  Olavo M Vasconcelos; Erika H Poehm; Robert J McCarter; William W Campbell; Zenaide M N Quezado
Journal:  J Gen Intern Med       Date:  2006-10       Impact factor: 5.128

4.  Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.

Authors:  A B Guttormsen; P M Ueland; I Nesthus; O Nygård; J Schneede; S E Vollset; H Refsum
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

5.  [A young patient with multiple arterial occlusions].

Authors:  C Panzere; A Brieke; B Bräuer; F Eggemann; H M Becker; P Dieterle
Journal:  Med Klin (Munich)       Date:  1998-05-15

Review 6.  High prevalence of cobalamin deficiency in the elderly.

Authors:  R H Allen; J Lindenbaum; S P Stabler
Journal:  Trans Am Clin Climatol Assoc       Date:  1996

7.  Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1998-03-21

Review 8.  Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy.

Authors:  H Nilsson-Ehle
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

Review 9.  The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia.

Authors:  J B Ubbink
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

Review 10.  Should all elderly people receive folate supplements?

Authors:  J B Ubbink
Journal:  Drugs Aging       Date:  1998-12       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.